For example, a study in The Lancet found that about 1-2% of participants experienced cramps
Other important side effects include gallbladder disease (cholelithiasis, cholecystitis), and potential worsening of diabetic retinopathy (particularly with rapid HbA1c reduction on semaglutide)
Many side effects occur early and improve over time, especially when doses are increased gradually, but some people need dose adjustments or a different medication
The FDA also provides a list of registered outsourcing facilities
Some people lose 15% of their body weight
Drug used in other indications Liraglutide Clinical Indications Beyond Obesity Primary Indication Liraglutide, a once-daily glucagon-like peptide-1 receptor agonist , is primarily approved for type 2 diabetes mellitus treatment, either as monotherapy or in combination with other medications